Singapore markets open in 3 hours 34 minutes

Omicron’s rapid spread shreds budding recovery in air travel

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (T14.SI)

SES - SES Delayed Price. Currency in USD
Add to watchlist
1.0500-0.0200 (-1.87%)
At close: 05:09PM SGT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.44B
Enterprise value 2.10B
Trailing P/E 6.20
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.75
Price/book (mrq)0.85
Enterprise value/revenue 0.30
Enterprise value/EBITDA 1.91

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 320.90%
S&P500 52-week change 324.02%
52-week high 31.3200
52-week low 30.8250
50-day moving average 31.0614
200-day moving average 31.0408

Share statistics

Avg vol (3-month) 3167.12k
Avg vol (10-day) 3105.05k
Shares outstanding 5200M
Implied shares outstanding 6773.44M
Float 8420.78M
% held by insiders 10.00%
% held by institutions 10.32%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.05
Forward annual dividend yield 44.30%
Trailing annual dividend rate 30.30
Trailing annual dividend yield 328.04%
5-year average dividend yield 43.86
Payout ratio 427.07%
Dividend date 3N/A
Ex-dividend date 415 Jun 2021
Last split factor 22:1
Last split date 330 Jun 2010

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Sep 2021


Profit margin 12.09%
Operating margin (ttm)9.84%

Management effectiveness

Return on assets (ttm)5.03%
Return on equity (ttm)14.20%

Income statement

Revenue (ttm)7B
Revenue per share (ttm)9.10
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)2.58B
EBITDA 804.16M
Net income avi to common (ttm)846.41M
Diluted EPS (ttm)0.1720
Quarterly earnings growth (yoy)29.80%

Balance sheet

Total cash (mrq)2.15B
Total cash per share (mrq)2.78
Total debt (mrq)31.71M
Total debt/equity (mrq)0.50
Current ratio (mrq)2.50
Book value per share (mrq)8.06

Cash flow statement

Operating cash flow (ttm)936.58M
Levered free cash flow (ttm)86.82M